Interpretation to 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
-
摘要: 《2023 ESC糖尿病合并心血管疾病管理指南》在2023年8月举行的欧洲心脏病学年会(ESC 2023)上重磅发布。该指南重视心血管病(CVD)、慢性肾病(CKD)与糖尿病(DM)之间的相互影响,以SGLT2i作为有力抓手,做到“心肾共治”,强调“以改善心肾结局为目标”的治疗理念。Abstract: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes were released at the European Society of Cardiology congress in August 2023. The guild line pay attention to the interaction between cardiovascular disease, chronic kidney disease and diabetes mellitus. Using SGLT2i as a powerful starting point to achieve cardio-renal co-treatment and emphasize the treatment concept of aiming to improve cardiovascular and renal outcomes.
-
Key words:
- cardiovascular disease /
- diabetes /
- ESC guideline update
-
-
[1] Marx N, Federici M, Schutt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes[J]. Eur Heart J, 2023, doi: 10.1093/eurheartj/ehad192.
-